Calcitriol Treatment in Metabolic Bone Disease of Prematurity with Elevated Parathyroid Hormone: A Preliminary Study
Conclusion Improvements in MBD markers and lack of serious adverse effects suggest calcitriol may be a treatment option in infants with MBD and secondary hyperparathyroidism.
Source: Journal of Clinical and Translational Endocrinology - Category: Endocrinology Source Type: research
More News: Calcium | Endocrinology | Hormones | Hyperparathyroidism | Study | Vitamin D Deficiency | Vitamins